TORONTO, ONTARIO--(Marketwire - June 17, 2008) - PharmEng International Inc. (“PharmEng”) (TSX VENTURE:PII),today announced that its wholly owned subsidiary, Keata Pharma Inc., is relocating contract manufacturing operations from the Perth, Ontario (“Perth”) facility to their state-of-the-art pharmaceutical manufacturing facility in Sydney, Nova Scotia. Included in the relocation from Perth are existing pharmaceutical supply contracts, manufacturing equipment and personnel.
